Artelo Biosciences, Inc. (ARTL) Misses Q2 EPS by 548c
Tweet
Share
E-mailGet Alerts ARTL Hot Sheet
Join SI Premium – FREE
Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($5.61), $5.48 worse than the analyst estimate of ($0.13).
For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADP Employment Change (Aug) 38K vs 47K Expected
- MongoDB (MDB) PT Lowered to $465 at Stifel
- Amprius unveils 500 Wh/kg battery cell for unmanned aviation
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
